Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNOT7 | Q9UIV1 | 3/20 | 0.50 |
| ▸ | PARN | O95453 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | PNP | P00491 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | CTSB | P07858 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7985306 | 0.99 | CNOT7 (0.51) | CNOT7PARNADORA3KMT2APNP | |
| SCHEMBL7985353 | 0.82 | KMT2A (0.56) | CNOT7PARNADORA3KMT2APNP | |
| SCHEMBL7974107 | 0.81 | CNOT7 (0.49) | CNOT7PARNKMT2APNPSMN1; SMN2 | |
| SCHEMBL7985301 | 0.81 | KMT2A (0.57) | CNOT7PARNADORA3KMT2APNP | |
| SCHEMBL7974027 | 0.77 | CNOT7 (0.57) | CNOT7PARNADORA3KMT2APNP | |
| SCHEMBL1713107 | 0.77 | PNP (0.61) | CNOT7PARNKMT2APNPSMN1; SMN2 | |
| SCHEMBL7975271 | 0.76 | CNOT7 (0.56) | CNOT7PARNADORA3KMT2APNP | |
| SCHEMBL7975254 | 0.75 | CNOT7 (0.55) | CNOT7PARNKMT2APNPSMN1; SMN2 | |
| SCHEMBL7988101 | 0.75 | CNOT7 (0.55) | CNOT7PARNKMT2APNPSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL7987472 | 0.74 | CNOT7 (0.54) | CNOT7PARNKMT2APNPSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6310070-B1 | FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS | JAPAN ENERGY CORPORATION (JP) | 2001-10-30 | — | — | US | disclosed |
| EP-0999211-A1 | NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF | JAPAN ENERGY CORPORATION (JP) | 2000-05-10 | — | — | EP | disclosed |